Literature DB >> 25078865

Neurodevelopmental impact of hydrocortisone exposure in extremely low birth weight infants: outcomes at 1 and 2 years.

K Patra1, M M Greene1, J M Silvestri1.   

Abstract

OBJECTIVE: Postnatal steroids are used in neonatal intensive care units despite known side effects. Hydrocortisone (HC) use persists as it is believed to have less deleterious effects on neurodevelopmental (ND) outcome compared to other steroids. The literature is sparse with respect to the ND impact of HC use in recent years. Hence, we sought to examine the effect of HC use on ND outcome in a contemporary cohort of extremely low birth weight (ELBW) infants. STUDY
DESIGN: A total of 175 ELBW infants (86 HC exposed, 89 steroid naive) born in 2008 to 2010 were compared for mortality, morbidity and ND outcome at 8 and 20 months corrected age. Outcome measures included neurologic exam and results of the Bayley Scales of Infant and Toddler Development-III (BSITD-III). Multiple regression analyses adjusted for the effect of other risk factors on outcome. RESULT: Overall, 65 (75%) of the HC and 74 (83%) of the no-HC groups survived to discharge. HC infants were smaller (mean birth weight (BW) 719 ± 127 g vs 837 ± 99 g) and of lower gestational age (GA) (mean GA 26.0 ± 1.7 weeks vs 27.5 ± 1.8 weeks) compared to the no-HC group. Patients in the HC group were more likely to be a multiple, have a severely abnormal head ultrasound, bronchopulmonary dysplasia, retinopathy of prematurity, necrotizing enterocolitis and receive treatment for patent ductus arteriosus and hypotension than those in the no-HC group. Of the HC group, the mean age at treatment was 20 ± 19 days, mean duration of treatment 49 ± 37 days. At 8 months, the HC group had lower mean motor (87 ± 18 vs 95 ± 15, P = 0.028) and fine motor (9 ± 2.9 vs 10.5 ± 2.6, P = 0.005) and higher rate of subnormal motor (44 vs 15%, P = 0.002) and fine motor scores (24 vs 6.5%, P = 0.017). In regression analyses, HC exposure >7 days was significantly related to worse outcome on fine motor scores at 8 months while cumulative days of HC exposure was a predictor of worse outcome on language at 8 months and motor outcome at 20 months. Each additional day of HC exposure increased the odds of subnormal receptive and expressive language in the first year of life by 4 and 2%, respectively, and increased odds of subnormal motor function by 2% in the 2nd year of life.
CONCLUSION: HC exposure for >7 days is associated with worse performance in fine motor skills in the first year of life, while cumulative HC exposure negatively impacts receptive and expressive language skills in the first year and motor skills in the second year of life after adjusting for neonatal and social risk factors.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25078865     DOI: 10.1038/jp.2014.133

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  20 in total

1.  Policy statement--postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia.

Authors:  Kristi L Watterberg
Journal:  Pediatrics       Date:  2010-09-06       Impact factor: 7.124

Review 2.  Postnatal hydrocortisone treatment for chronic lung disease in the preterm newborn and long-term neurodevelopmental follow-up.

Authors:  K J Rademaker; L S de Vries; C S P M Uiterwaal; F Groenendaal; D E Grobbee; F van Bel
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-09-11       Impact factor: 5.747

3.  Are outcomes of extremely preterm infants improving? Impact of Bayley assessment on outcomes.

Authors:  Betty R Vohr; Bonnie E Stephens; Rosemary D Higgins; Carla M Bann; Susan R Hintz; Abhik Das; Jamie E Newman; Myriam Peralta-Carcelen; Kimberly Yolton; Anna M Dusick; Patricia W Evans; Ricki F Goldstein; Richard A Ehrenkranz; Athina Pappas; Ira Adams-Chapman; Deanne E Wilson-Costello; Charles R Bauer; Anna Bodnar; Roy J Heyne; Yvonne E Vaucher; Robert G Dillard; Michael J Acarregui; Elisabeth C McGowan; Gary J Myers; Janell Fuller
Journal:  J Pediatr       Date:  2012-03-14       Impact factor: 4.406

4.  Follow up studies during the first five years of life: a pervasive assessment of neurological function.

Authors:  C Amiel-Tison; A Stewart
Journal:  Arch Dis Child       Date:  1989-04       Impact factor: 3.791

5.  Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age.

Authors:  T M O'Shea; J M Kothadia; K L Klinepeter; D J Goldstein; B G Jackson; R G Weaver; R G Dillard
Journal:  Pediatrics       Date:  1999-07       Impact factor: 7.124

6.  Time-related changes in steroid use and bronchopulmonary dysplasia in preterm infants.

Authors:  Bradley A Yoder; Megan Harrison; Reese H Clark
Journal:  Pediatrics       Date:  2009-07-20       Impact factor: 7.124

7.  Short- and long-term effects of neonatal glucocorticoid therapy: is hydrocortisone an alternative to dexamethasone?

Authors:  M van der Heide-Jalving; P J G H Kamphuis; M J van der Laan; J M Bakker; V M Wiegant; C J Heijnen; S Veen; F van Bel
Journal:  Acta Paediatr       Date:  2003-07       Impact factor: 2.299

8.  Evolving neonatal steroid prescription habits and patient outcomes.

Authors:  Etienne Fortin-Pellerin; Claire Petersen; Francine Lefebvre; Keith J Barrington; Annie Janvier
Journal:  Acta Paediatr       Date:  2013-05-15       Impact factor: 2.299

9.  Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity.

Authors:  Tsu F Yeh; Yuh J Lin; Hung C Lin; Chao C Huang; Wu S Hsieh; Chyi H Lin; Cheng H Tsai
Journal:  N Engl J Med       Date:  2004-03-25       Impact factor: 91.245

10.  A new growth chart for preterm babies: Babson and Benda's chart updated with recent data and a new format.

Authors:  Tanis R Fenton
Journal:  BMC Pediatr       Date:  2003-12-16       Impact factor: 2.125

View more
  3 in total

1.  Duration of mechanical ventilation is more critical for brain growth than postnatal hydrocortisone in extremely preterm infants.

Authors:  Chloé Rousseau; Marine Guichard; Elie Saliba; Baptiste Morel; Geraldine Favrais
Journal:  Eur J Pediatr       Date:  2021-05-16       Impact factor: 3.183

2.  Neurodevelopmental Outcomes of Extremely Preterm Infants Randomized to Stress Dose Hydrocortisone.

Authors:  Nehal A Parikh; Kathleen A Kennedy; Robert E Lasky; Jon E Tyson
Journal:  PLoS One       Date:  2015-09-16       Impact factor: 3.240

Review 3.  Drug therapy for the prevention and treatment of bronchopulmonary dysplasia.

Authors:  Anjali Iyengar; Jonathan M Davis
Journal:  Front Pharmacol       Date:  2015-02-16       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.